Canagliflozin Audit DUK Liverpool, 2019 - Abstract

Two year metabolic outcomes in the Association of British Clinical Diabetologist (ABCD) Nationwide Canagliflozin Audit: a comparison of glycaemic improvements

Dr A Puttanna*1, Dr M Yadagiri1, Dr P Sen Gupta1, Dr IW Gallen2, Dr A Bickerton3, Dr S Phillips4, Dr A Evans4, Dr D Sennik5, Dr REJ Ryder1, ABCD nationwide canagliflozin audit contributors6

1Diabetes and Endocrinology, Sandwell and West Birmingham NHS Trust, Birmingham, UK

2Diabetes and Endocrinology, Royal Berkshire Hospitals NHS Trust, Berkshire, UK

3Diabetes and Endocrinology, Yeovil District Hospital NHS Trust, Yeovil, UK

4Diabetes and Endocrinology, Cheltenham General Hospital, Cheltenham, UK

5Diabetes and Endocrinology, Princess Alexandra Hospital, Harlow, UK

6ABCD Nationwide Canagliflozin Audit contributors, UK


Clinical taxonomy: 
Treatments for diabetes
Type 2 diabetes mellitus
Resource taxonomy: 

Information for HCPs

COVID-19 Information for Healthcare Professionals